Details for Patent: 8,492,441
✉ Email this page to a colleague
Which drugs does patent 8,492,441 protect, and when does it expire?
Patent 8,492,441 protects MAYZENT and is included in one NDA.
This patent has forty-seven patent family members in thirty-four countries.
Summary for Patent: 8,492,441
| Title: | Dosage regimen of an S1P receptor agonist |
| Abstract: | S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage. |
| Inventor(s): | Legangneux; Eric (Basel, CH) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 12/655,049 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,492,441
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | MAYZENT | siponimod | TABLET;ORAL | 209884-001 | Mar 26, 2019 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING SIPONIMOD USING A TITRATION SCHEME TO REACH A MAINTENANCE DOSE | ⤷ Subscribe | ||||
| Novartis | MAYZENT | siponimod | TABLET;ORAL | 209884-003 | Aug 24, 2021 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING SIPONIMOD USING A TITRATION SCHEME TO REACH A MAINTENANCE DOSE | ⤷ Subscribe | ||||
| Novartis | MAYZENT | siponimod | TABLET;ORAL | 209884-002 | Mar 26, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING SIPONIMOD USING A TITRATION SCHEME TO REACH A MAINTENANCE DOSE | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,492,441
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 09167209 | Aug 4, 2009 | |
International Family Members for US Patent 8,492,441
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2379069 | ⤷ Subscribe | 301046 | Netherlands | ⤷ Subscribe |
| European Patent Office | 2379069 | ⤷ Subscribe | CA 2020 00026 | Denmark | ⤷ Subscribe |
| European Patent Office | 2379069 | ⤷ Subscribe | 122020000025 | Germany | ⤷ Subscribe |
| European Patent Office | 2379069 | ⤷ Subscribe | LUC00160 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 2379069 | ⤷ Subscribe | PA2020513 | Lithuania | ⤷ Subscribe |
| European Patent Office | 2379069 | ⤷ Subscribe | 132020000000076 | Italy | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
